Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

Marijuana Rescheduled by DOJ and DEA

FDA-approved products and state-regulated medical products are now Schedule III, effective immediately.
Read More →
April 27, 2026

Insights from the 2026 IAIABC Forum

Discussions centered around evolving approaches to carrier compliance and oversight, reflecting an increasing shift toward data-driven system alignment.
Read More →
April 27, 2026

Insights From the Delaware/Pennsylvania WCRB Forum

Among many educational sessions, Sandy Shtab, Healthesystems VP of Industry and State Affairs, joined a panel on Medical Experience.
Read More →
April 27, 2026

White House Issues Executive Order on Psychedelics

The order seeks to accelerate clinical trials, data sharing, drug approvals, and possibly rescheduling.
Read More →
April 27, 2026

Minnesota Publishes Drug Price Transparency Report

Prescription drug list prices increased 23% in the last year, far outpacing inflation.
Read More →
April 27, 2026

New York Could Exclude Unpaid Interns from Workers’ Comp

Such interns would not be considered employees, meaning they would not be entitled to various employee benefits.
Read More →
April 27, 2026

Oklahoma Employers Can Terminate Employees for Any Marijuana Use

Positive drug tests, even for medical use, can result in termination. The bill also updates rules around safety sensitive positions.
Read More →
April 27, 2026

Pennsylvania Advisory Council Signals Legislative Attention Needed on Topical Cap

Senate Bill 1215 was discussed, and it appears unlikely the proposed reimbursement caps will be passed.
Read More →
April 20, 2026

California P&T Committee Recommends Formulary Updates

The committee issued new recommendations related to 300 mg ibuprofen, gabapentin and pregabalin, cyclobenzaprine, and tizanidine.
Read More →
April 20, 2026
1 … 5 6 7 8 9 … 57

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Cybersecurity Strategies to Balance Innovation & Caution in the Age of AI

Healthesystems AVP of Information & Technology Security, Tony Brown, will speak about this topic at the 2025 IAIABC Convention.
Read More

Tracking Sub-Regulatory Changes in Workers’ Comp

Healthe’s VP of Industry and State Affairs, Sandy Shtab, shares her thoughts with Risk & Insurance magazine in a recent article.
Read More

FDA Orders Opioid Manufacturers to Update Prescribing Information for Long-Term Use

All opioid manufacturers must update their drug labeling to align with a list of notes provided by the FDA.
Read More

Burden of Proof: Unpacking Presumptions in Workers’ Comp

Exploring the expansion of presumptions in PTSD, cancers, and more.
Read More

FDA Takes Steps to Restrict Certain Kratom Products

The FDA recommended concentrated 7-OH kratom products to be rescheduled under the Controlled Substances Act.
Read More

The Emerging Role of AI in Workers’ Comp – and the Regulations Surrounding It

An expert Q&A with Sandy Shtab, VP of Industry and State Affairs, on AI in workers’ comp and the regulations surrounding it.
Read More
1 … 5 6 7 8 9 … 51
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle